NEW YORK, June 11, 2024 /PRNewswire/ -- Kindbody, the leading national fertility clinic network and global family-building benefits provider for employers, today announced its Founder and Executive Chairman, Gina Bartasi, will return as the company's CEO during a time of unprecedented growth. The Company recently shared that it expected to deliver revenue in the range of $225-$250 million for 2024 and is now profitable after years of significant investment into new clinic locations and proprietary technolog ...

Progyny (NASDAQ:PGNY) has not received much love lately after reporting a topline miss in their Q1 2024 call on May 9th, with the stock dropping around 15%. Management attributed the miss to a decline in utilization rates that coincided with an Alabama's supreme court ruling that embryos should have the same legal rights as persons. The utilization decline was more pronounced in red states, according to management. Yet, the long-term prospects remain stable in my opinion. Two secular tailwinds present signi ...

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny's Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 9:00 A.M. Eastern Time. A live audiocast and replay will be available from the Events and Presentations section of Progyny's website at http://investors.progyny.com. About ...

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny's Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 9:00 A.M. Eastern Time. A live audiocast and replay will be available from the Events and Presentations section of Progyny's website at http://investors.progyny.com. About ...

Investment action I recommended a buy rating for Progyny, Inc. (NASDAQ:PGNY) when I wrote about it in mid-March this year, as I continued to view the long-term growth outlook as attractive. Based on my current outlook and analysis, I recommend a buy rating. My key update to my thesis is that I don't think the weakness in 1Q24 revenue is indicative of a structural long-term impairment to growth. Historical US ART cycles suggest a solid long-term growth trend, and any downturn is typically met with a strong r ...

NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, announced today that its Board of Directors has approved a share repurchase program to repurchase up to $100 million of its common stock. This follows the program that was previously announced on February 29, 2024. The program will be funded through available cash balances. Shares may be repurchased through open market repurchases, including through plan ...

NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, announced today that its Board of Directors has approved a share repurchase program to repurchase up to $100 million of its common stock. This follows the program that was previously announced on February 29, 2024. The program will be funded through available cash balances. Shares may be repurchased through open market repurchases, including through plan ...

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Progyny's executives will participate in a fireside chat at the BofA Securities 2024 Healthcare Conference on Wednesday, May 15, 2024, at 5:00 P.M. Pacific Time / 8:00 P.M. Eastern Time. They will also participate in a fireside chat at the Leerink Partners Healthcare Crossroads Conference 2024 on Wednesday, May 29, 2024, at 1:00 P.M. ...

And as we sit here now, even for Q2 has returned back to normal. Your example is correct. The order of magnitude in terms of the shift wasnÂ't that dramatic, but it was dramatic enough that it impacted what you would expect for revenue in the quarter when you look at the utilizers. Okay. Has there been any changes in coverage that could be impacting that mix shift? So if that mix shift occurred before this Alabama Supreme Court activity, like, was it coverage decisions on the part of health plans, where may ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | | --- | --- | --- | | Common Stock, | PGNY | The Nasdaq Global Select Market | | $0.0001 par value per share | | | Securities registered pursuant to Section 12(g) of the Act: None ...